Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities
Majed Ghattas(Polytechnique Montréal), Mohamad‐Gabriel Alameh(Children's Hospital of Philadelphia), Marc Lavertu(Polytechnique Montréal), Garima Dwivedi(Massachusetts Institute of Technology)
Cited by 227
Related Papers
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
|Immunity|2021|713
An ionizable lipid toolbox for RNA delivery
|Nature Communications|2021|581
Nanomaterial Delivery Systems for mRNA Vaccines
|Vaccines|2021|546
Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration
|Communications Biology|2021|406
Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination
|Science Immunology|2022|366